All Stories

  1. Hospital discharge using salbutamol as required after acute attacks of wheeze in children: a service evaluation

    Article • Archives of Disease in Childhood, November 2023, BMJ

    Gary Connett

  2. The tracheal system of the Common Wasp (Vespula vulgaris) – A micro-CT study

    Article • Journal of Insect Physiology, September 2023, Elsevier

    Gary Connett

  3. Asthma, classical conditioning, and the autonomic nervous system – a hypothesis for why children wheeze

    Article • Archives of Disease in Childhood, August 2023, BMJ

    Gary Connett

  4. Elexacaftor–Tezacaftor–Ivacaftor improves exercise capacity in adolescents with cystic fibrosis

    Article • Pediatric Pulmonology, July 2022, Wiley

    Gary Connett

  5. Structured transition is associated with improved outcomes in diabetes

    Article • Practical Diabetes, January 2022, Wiley

    Gary Connett

  6. Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials

    Article • Thorax, September 2021, BMJ

    Gary Connett

  7. Meconium Ileus due to GUCY2C gene mutations in three unrelated South Indian families

    Article • Journal of Cystic Fibrosis, September 2021, Elsevier

    Gary Connett

  8. The impact of plasma 25‐hydroxyvitamin D on pulmonary function and exercise physiology in cystic fibrosis: A multicentre retrospective study

    Article • Journal of Human Nutrition and Dietetics, June 2021, Wiley

    Gary Connett

  9. Evaluation of the impact of shielding to avoid COVID-19 infection on respiratory symptoms in children with severe asthma

    Article • Archives of Disease in Childhood, October 2020, BMJ

    Gary Connett

  10. Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis

    Article • Redox Biology, May 2020, Elsevier

    Gary Connett

  11. The implications of dysglycaemia on aerobic exercise and ventilatory function in cystic fibrosis

    Article • Journal of Cystic Fibrosis, May 2020, Elsevier

    Gary Connett

  12. A public health emergency among young people

    Article • The Lancet Respiratory Medicine, March 2020, Elsevier

    Gary Connett

  13. A rational approach to e-cigarettes: challenging ERS policy on tobacco harm reduction

    Article • European Respiratory Journal, February 2020, European Respiratory Society (ERS)

    Jørgen Vestbo, Gary Connett

  14. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

    Article • The Lancet, November 2019, Elsevier

    Gary Connett

  15. Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa

    Article • Journal of Antimicrobial Chemotherapy, September 2019, Oxford University Press (OUP)

    Gary Connett

  16. The journey of lumacaftor-ivacaftor from bench to bedside

    Article • Drug Design Development and Therapy, July 2019, Dove Medical Press

    Gary Connett

  17. Reply to Askew and Green

    Article • Journal of Applied Physiology, February 2019, American Physiological Society

    Gary Connett

  18. Determining the reasons for poorly controlled asthma in an adolescent

    Article • BMJ, January 2019, BMJ

    Gary Connett

  19. Airway Microbiome and Development of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review

    Article • The Journal of Pediatrics, January 2019, Elsevier

    Gary Connett

  20. Psychometric evaluation of a patient-reported outcome measure in pancreatic exocrine insufficiency (PEI)

    Article • Pancreatology, January 2019, Elsevier

    Gary Connett

  21. Reply to Cooper

    Article • Journal of Applied Physiology, January 2019, American Physiological Society

    Gary Connett

  22. Dysfunctional Breathing in Children and Adults With Asthma

    Article • Frontiers in Pediatrics, December 2018, Frontiers

    Gary Connett

  23. Cardiopulmonary exercise testing with supramaximal verification produces a safe and valid assessment of V̇o2max in people with cystic fibrosis: a retrospective analysis

    Article • Journal of Applied Physiology, October 2018, American Physiological Society

    Gary Connett

  24. Evaluation of a regionally based preceptorship programme for newly qualified neonatal nurses

    Article • Journal of Neonatal Nursing, August 2018, Elsevier

    Gary Connett

  25. Ready, Steady, Go – Achieving successful transition in cystic fibrosis

    Article • Paediatric Respiratory Reviews, June 2018, Elsevier

    Gary Connett

  26. The use of lumacaftor/ivacaftor to treat acute deterioration in paediatric cystic fibrosis

    Article • Paediatric Respiratory Reviews, June 2018, Elsevier

    Gary Connett

  27. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis

    Article • Molecular Therapy, September 2017, Elsevier

    Gary Connett, Bernadette Fernandez

  28. Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis

    Article • FEMS Microbiology Letters, June 2017, Oxford University Press (OUP)

    Gary Connett

  29. Contributions of Composition and Interactions to Bacterial Respiration Are Reliant on the Phylogenetic Similarity of the Measured Community

    Article • Microbial Ecology, April 2017, Springer Science + Business Media

    Gary Connett

  30. Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument

    Article • The Patient Patient-Centered Outcomes Research, March 2017, Springer Science + Business Media

    Gary Connett

  31. Cephalosporin-3′-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms

    Article • Antimicrobial Agents and Chemotherapy, December 2016, ASM Journals

    Gary Connett

  32. Pseudomonas aeruginosainfection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches

    Article • Expert Review of Respiratory Medicine, May 2016, Taylor & Francis

    Gary Connett

  33. Cystic Fibrosis Nutrition – Chewing the Fat

    Article • Paediatric Respiratory Reviews, January 2016, Elsevier

    Gary Connett

  34. Nutritional outcomes in cystic fibrosis – are we doing enough?

    Article • Paediatric Respiratory Reviews, October 2015, Elsevier

    Gary Connett

  35. Routine use of daily oral vitamin K to treat infants with cystic fibrosis

    Article • Paediatric Respiratory Reviews, October 2015, Elsevier

    Gary Connett

  36. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study

    Article • Therapeutic Advances in Respiratory Disease, September 2015, SAGE Publications

    Gary Connett

  37. G385 RATNO - Reducing Antibiotic Tolerance using Nitric Oxide in Cystic Fibrosis: report of a proof of concept clinical trial

    Article • Archives of Disease in Childhood, April 2014, BMJ

    Gary Connett

  38. Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis

    Article • Journal of Cystic Fibrosis, January 2013, Elsevier

    Gary Connett

  39. Self-assessment

    Article • Paediatrics and Child Health, January 2013, Elsevier

    Gary Connett

  40. Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial

    Article • The Clinical Respiratory Journal, August 2012, Wiley

    Gary Connett

  41. A Population-Based Study of Fish Allergy in the Philippines, Singapore and Thailand

    Article • International Archives of Allergy and Immunology, January 2012, Karger Publishers

    Gary Connett

  42. A Quantitative Analysis of Ureaplasma urealyticum and Ureaplasma parvum Compared with Host Immune Response in Preterm Neonates at Risk of Developing Bronchopulmonary Dysplasia

    Article • Journal of Clinical Microbiology, December 2011, ASM Journals

    Gary Connett

  43. Primary Tracheomalacia and Persistent Wheezing in Cystic Fibrosis During Infancy

    Article • Journal of Bronchology & Interventional Pulmonology, April 2011, Wolters Kluwer Health

    Gary Connett

  44. A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis

    Article • Expert Opinion on Drug Safety, February 2011, Informa Healthcare

    Gary Connett

  45. Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer

    Article • Alimentary Pharmacology & Therapeutics, November 2010, Wiley

    Gary Connett

  46. Manifesting carriage of a Duchenne muscular dystrophy mutation: an unusual cause of impaired lung function in CF

    Article • Journal of the Royal Society of Medicine, June 2010, SAGE Publications

    Gary Connett

  47. Molecular Microbiological Characterization of Preterm Neonates at Risk of Bronchopulmonary Dysplasia

    Article • Pediatric Research, April 2010, Springer Science + Business Media

    Gary Connett

  48. The use of culture-independent tools to characterize bacteria in endo-tracheal aspirates from pre-term infants at risk of bronchopulmonary dysplasia

    Article • Journal of Perinatal Medicine, January 2010, De Gruyter

    Gary Connett

  49. Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches

    Article • BMC Pulmonary Medicine, April 2009, Springer Science + Business Media

    Gary Connett

  50. Colloidal silver for lung disease in cystic fibrosis

    Article • Journal of the Royal Society of Medicine, July 2008, SAGE Publications

    Gary Connett

  51. Acute intestinal obstruction as a presentation of cystic fibrosis in infancy

    Article • Journal of Cystic Fibrosis, July 2008, Elsevier

    Gary Connett

  52. British Guideline on the Management of Asthma

    Article • Thorax, May 2008, BMJ

    Professor David Price, Gary Connett

  53. Cystic Fibrosis Diagnosed After 2 Months of Age Leads to Worse Outcomes and Requires More Therapy

    Article • PEDIATRICS, January 2007, American Academy of Pediatrics (AAP)

    Gary Connett

  54. Idiopathic Bilateral Vocal Cord Palsy in Extremely Premature Neonates

    Article • Journal of Bronchology, October 2006, Wolters Kluwer Health

    Gary Connett

  55. Chest x ray and high-resolution computed tomography in cystic fibrosis

    Article • Archives of Disease in Childhood, July 2006, BMJ

    Gary Connett

  56. Use of 16S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic Fibrosis

    Article • Journal of Clinical Microbiology, July 2006, ASM Journals

    Gary Connett

  57. Juvenile Laryngeal Papillomatosis

    Article • Primary Care Respiratory Journal, April 2006, Springer Science + Business Media

    Gary Connett

  58. Resolution of peanut allergy following bone marrow transplantation for primary immunodeficiency

    Article • Allergy, April 2005, Wiley

    Gary Connett

  59. The prevalence of stress urinary incontinence in patients with cystic fibrosis: an under-recognized problem

    Article • Journal of Pediatric Urology, February 2005, Elsevier

    Gary Connett

  60. Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis

    Article • Clinical Nutrition, June 2004, Elsevier

    Gary Connett

  61. A rare cause of upper airway obstruction in a 5-year-old girl: a laryngeal web

    Article • Pediatric Anesthesia, October 2003, Wiley

    Gary Connett

  62. Clinical application of direct sputum sensitivity testing in a severe infective exacerbation of cystic fibrosis

    Article • Pediatric Pulmonology, May 2003, Wiley

    Gary Connett

  63. Falsely elevated serum tobraycin levels in a patient receiving nebulised tobramycin

    Article • Journal of Cystic Fibrosis, September 2002, Elsevier

    Gary Connett

  64. Long term results of lung resection in cystic fibrosis patients with localised lung disease

    Article • Archives of Disease in Childhood, January 2002, BMJ

    Gary Connett

  65. Bronchoalveolar lavage

    Article • Paediatric Respiratory Reviews, March 2000, Elsevier

    Gary Connett

  66. Somatizing disorders affecting the respiratory tract

    Article • The Indian Journal of Pediatrics, February 2000, Springer Science + Business Media

    Gary Connett

  67. Editorial

    Article • The Indian Journal of Pediatrics, February 2000, Springer Science + Business Media

    Gary Connett

  68. Diagnosis of cystic fibrosis : Indian perspective

    Article • The Indian Journal of Pediatrics, November 1999, Springer Science + Business Media

    Gary Connett

  69. Faecal Elastase 1: A Marker of Exocrine Pancreatic Insufficiency in Cystic Fibrosis

    Article • Annals of Clinical Biochemistry International Journal of Laboratory Medicine, November 1999, SAGE Publications

    Gary Connett

  70. Pancreatic enzymes and fibrosing colonopathy

    Article • The Lancet, July 1999, Elsevier

    Gary Connett

  71. A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital

    Article • Archives of Disease in Childhood, May 1999, BMJ

    Gary Connett

  72. Colonic wall thickening is related to age and not dose of high strength pancreatin microspheres in children with cystic fibrosis

    Article • European Journal of Gastroenterology & Hepatology, February 1999, Wolters Kluwer Health

    Gary Connett

  73. Interferon alpha  treatment of molluscum contagiosum in immunodeficiency

    Article • Archives of Disease in Childhood, January 1999, BMJ

    Gary Connett

  74. Diffuse Microcystic Pancreatic Enlargement in a Cystic Fibrosis Patient Causing Severe Gastrointestinal Symptoms and Successfully Treated by Total Pancreatectomy

    Article • Journal of Pediatric Gastroenterology and Nutrition, April 1998, Wolters Kluwer Health

    Gary Connett

  75. Inflammatory pseudotumor of the trachea in a ten-month-old infant

    Article • Pediatric Pulmonology, April 1997, Wiley

    Gary Connett

  76. Dietary fibre and the occurrence of gut symptoms in cystic fibrosis

    Article • Archives of Disease in Childhood, January 1997, BMJ

    Gary Connett

  77. Use of a reformulated Oka strain varicella vaccine (SmithKline Beecham Biologicals/Oka) in healthy children

    Article • European Journal of Pediatrics, August 1996, Springer Science + Business Media

    Gary Connett

  78. Use of a reformulated Oka strain varicella vaccine (SmithKline Beecham Biologicals/Oka) in healthy children

    Article • European Journal of Pediatrics, July 1996, Springer Science + Business Media

    Gary Connett

  79. Flexible fibre-optic bronchoscopy in the management of lung complications in cystic fibrosis

    Article • Acta Paediatrica, June 1996, Wiley

    Gary Connett

  80. Lung resection in cystic fibrosis patients with localised pulmonary disease.

    Article • Archives of Disease in Childhood, May 1996, BMJ

    Gary Connett

  81. Veno-venous haemodiafiltration in meningococcal septicaemia

    Article • The Lancet, March 1996, Elsevier

    Gary Connett

  82. Bronchoscopic appearances of congenital lobar emphysema

    Article • Pediatric Pulmonology, March 1996, Wiley

    Gary Connett

  83. Effects of an acaricide on asthmatic children with house dust mite allergy

    Article • Pediatrics International, December 1994, Wiley

    Gary Connett

  84. Lung function reference values in Singaporean children aged 6-18 years.

    Article • Thorax, September 1994, BMJ

    Gary Connett

  85. Day care and asthma morbidity

    Article • Journal of Paediatrics and Child Health, June 1994, Wiley

    Gary Connett

  86. Treating childhood asthma in Singapore: when West meets East

    Article • BMJ, May 1994, BMJ

    Gary Connett

  87. Prednisolone and salbutamol in the hospital treatment of acute asthma.

    Article • Archives of Disease in Childhood, March 1994, BMJ

    Gary Connett

  88. Use of budesonide in severe asthmatics aged 1-3 years.

    Article • Archives of Disease in Childhood, September 1993, BMJ

    Gary Connett

  89. Audit strategies to reduce hospital admissions for acute asthma.

    Article • Archives of Disease in Childhood, August 1993, BMJ

    Gary Connett

  90. Use of pulse oximetry in the hospital management of acute asthma in childhood

    Article • Pediatric Pulmonology, June 1993, Wiley

    Gary Connett

  91. Prolonged hypoxaemia after nebulised salbutamol.

    Article • Thorax, May 1993, BMJ

    Gary Connett

  92. Prevention of viral induced asthma attacks using inhaled budesonide.

    Article • Archives of Disease in Childhood, January 1993, BMJ

    Gary Connett

  93. Inhaled budesonide and behavioural disturbances

    Article • The Lancet, September 1991, Elsevier

    Gary Connett

  94. Acute wheezy bronchitis--lumping and splitting.

    Article • Archives of Disease in Childhood, June 1991, BMJ

    Gary Connett